Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep:349:354-366.
doi: 10.1016/j.jconrel.2022.07.006. Epub 2022 Jul 12.

Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis

Yang Mai  1 , Yaqi Ouyang  1 , Mian Yu  1 , Yujia Qin  1 , Michael Girardi  2 , W Mark Saltzman  3 , Emiliano Cocco  4 , Chao Zhao  5 , Liu Yu  1 , Yizhen Jia  1 , Lingyun Xiao  1 , Liu Dou  1 , Wenbin Deng  1 , Yang Liu  6 , Julin Xie  7 , Yang Deng  8
Affiliations

Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis

Yang Mai et al. J Control Release. 2022 Sep.

Abstract

First-line treatments for mild to moderate psoriasis are typically topical formulations containing corticosteroids, however, the therapeutic efficacy of these formulations is compromised by limited penetration and skin retention. Even more challenging, off-target corticosteroids are known to adversely affect healthy skin, including induction of epidermal and dermal atrophy. Here, we report a nanoparticle-based topical formulation that cures psoriasis in a single dose, but leaves healthy skin intact. Specifically, we developed tris(hydroxymethyl)aminomethane-modified bioadhesive nanoparticles (Tris-BNPs) that exploit the high permeability characteristic of psoriasis to penetrate only psoriatic skin but not the healthy skin. Furthermore, as Tris-BNPs diffuse and penetrate into the epidermis, the Tris molecules slowly diffuse away, exposing the aldehyde groups of BNPs, which can bind to amine groups present within lesional skin, leading to long local retention of BNPs in lesions of psoriatic skin. The accumulated BNPs within lesions release corticosteroids over a ~ 3 day period to maintain local drug concentration above the therapeutic level. In addition to deeper penetration and longer retention compared with commercial psoriasis treatments, the topical applied Tris-BNPs were not affected by sweating, humidity, or active wiping due to their preferential accumulation between the stratum corneum and the basal cells of the epidermis. Overall, Tris-BNP as a topical formulation hold promise to overcome the limitations of current psoriasis treatment.

Keywords: Disease-specific treatment; Formulation optimization; Local drug delivery; Psoriasis; Single-dose cure; Surface-modified nanoparticles.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources